GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Telmisartan

Company
Baylor Research Institute
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
9 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

9 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Telmisartan and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02735707

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

    Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
    Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Recruiting NCT NCT06168487

    Telmisartan in Prostate Cancer

    Not yet reported Tyler J Curiel 36 participants Est. completion 2027-04-01 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06495710

    Arterial Stiffness and Blood Pressure

    Not yet reported VA Office of Research and Development 228 participants Est. completion 2028-12-31 3 sites Stand-alone
    Other conditions: Hypertension, Vascular Stiffness, Aging
    View official trial listing →
  • Recruiting NCT NCT06647745

    A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension

    Not yet reported THPharm Corp. 221 participants Est. completion 2026-12-01 2 sites Stand-alone
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06815497

    Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer

    Not yet reported Tyler J Curiel 33 participants Est. completion 2029-05-14 2 sites Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT07207057

    Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial

    Not yet reported University College, London 1200 participants Est. completion 2031-07-31 2 sites Stand-alone
    Other conditions: Parkinsons Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07499440

    Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder

    Not yet reported HB BioTech, LLC 200 participants Est. completion 2027-10 16 sites Stand-alone
    Other conditions: PTSD, Mental Illness
    View official trial listing →
  • Recruiting NCT NCT07588932

    Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors

    Not yet reported Spaulding Rehabilitation Hospital 50 participants Est. completion 2028-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00034840

    Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

    Not yet reported Boehringer Ingelheim 490 participants Est. completion 2002-08 35 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00133185

    A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

    Not yet reported Boehringer Ingelheim 31 participants Est. completion 2005-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00144222

    Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy

    Not yet reported Boehringer Ingelheim 218 participants Est. completion 2005-08 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00146289

    The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

    Not yet reported Boehringer Ingelheim 138 participants 17 sites
    Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00146341

    Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

    Not yet reported Boehringer Ingelheim 345 participants Est. completion 2006-09 9 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00147264

    Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial

    Not yet reported McMaster University 120 participants Est. completion 2006-11 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00153023

    1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

    Not yet reported Boehringer Ingelheim 885 participants Est. completion 2005-12 111 sites
    Other conditions: Diabetic Nephropathies, Hypertension
    View official trial listing →
  • Completed NCT NCT00153049

    3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

    Not yet reported Boehringer Ingelheim 583 participants Est. completion 2005-06 24 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00153062

    PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

    Not yet reported Boehringer Ingelheim 20332 participants 667 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00153088

    INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy

    Not yet reported Boehringer Ingelheim 527 participants Est. completion 2005-11 160 sites
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT00153101

    Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

    Not yet reported Boehringer Ingelheim 31546 participants 732 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00168779

    Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

    Not yet reported Boehringer Ingelheim 1185 participants Est. completion 2006-07 113 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00168857

    A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

    Not yet reported Boehringer Ingelheim 860 participants 109 sites
    Other conditions: Hypertension, Diabetic Nephropathies
    View official trial listing →
  • Terminated NCT NCT00185705

    Treatment of Insulin Resistance in Hypertensive, Obese Adolescents

    Not yet reported Stanford University 30 participants Est. completion 2007-07 1 site
    Other conditions: Hypertension, Insulin Resistance, Dyslipidemia
    View official trial listing →
  • Terminated NCT NCT00208221

    Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal 50 participants Est. completion 2007-06 1 site
    Type 2 diabetes Other conditions: Hypertension, Albuminuria
    View official trial listing →
  • Completed NCT NCT00221845

    Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients

    Not yet reported Heidelberg University 400 participants Est. completion 2010-01 33 sites Stand-alone
    Other conditions: Children, Chronic Renal Failure, Hypertension, Acquired Kidney Disease, Congenital Kidney Disease
    View official trial listing →
  • Completed NCT NCT00239369

    Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

    Not yet reported Boehringer Ingelheim 713 participants Est. completion 2006-08 84 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00239538

    SMOOTH - Blood Pressure Control in Diabetic/Obese Patients

    Not yet reported Boehringer Ingelheim 840 participants Est. completion 2004-12 102 sites
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00240422

    Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes

    Not yet reported Boehringer Ingelheim 96 participants Est. completion 2004-07 6 sites
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00240448

    A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

    Not yet reported Boehringer Ingelheim 1109 participants 100 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00240474

    A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)

    Not yet reported Boehringer Ingelheim 1000 participants Est. completion 2004-03 73 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00242814

    Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities

    Not yet reported Boehringer Ingelheim 100 participants 31 sites
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00257491

    Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Boehringer Ingelheim 29 participants Est. completion 2006-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00267943

    Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients

    Not yet reported Boehringer Ingelheim 639 participants Est. completion 2007-01 78 sites
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00274105

    SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients

    Not yet reported Boehringer Ingelheim 22 participants Est. completion 2004-10-01 2 sites
    Other conditions: Hypertension, Coronary Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00274118

    DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

    Not yet reported Boehringer Ingelheim 250 participants Est. completion 2004-01 37 sites
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00274144

    Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism

    Not yet reported Boehringer Ingelheim 42 participants Est. completion 2004-05 1 site
    Other conditions: Hypertension, Coronary Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00274599

    PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN

    Not yet reported Boehringer Ingelheim 812 participants 74 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00274612

    Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

    Not yet reported Boehringer Ingelheim 801 participants Est. completion 2003-11 62 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00274638

    PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

    Not yet reported Boehringer Ingelheim 805 participants 69 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00281580

    Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension

    Not yet reported Boehringer Ingelheim 1461 participants 136 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00281593

    Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension

    Not yet reported Boehringer Ingelheim 1354 participants 119 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00283686

    HALT Progression of Polycystic Kidney Disease Study A

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 558 participants Est. completion 2014-06 7 sites
    Other conditions: Kidney, Polycystic
    View official trial listing →
  • Status unknown NCT NCT00288717

    Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients

    Not yet reported Saitama Medical University 300 participants Est. completion 2007-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00295542

    Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

    Not yet reported University of Vigo 3344 participants Est. completion 2009-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00316095

    Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia

    Not yet reported Boehringer Ingelheim 1695 participants Est. completion 2007-08 92 sites
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT00326768

    Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension

    Not yet reported Boehringer Ingelheim 184 participants Est. completion 2007-08 3 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00407862

    Telmisartan and Losartan in Hypertensive IGT

    Not yet reported Medical University of Graz 24 participants Est. completion 2006-06 1 site
    Prediabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00421863

    Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study

    Not yet reported Heart Care Foundation 1111 participants Est. completion 2009-01 45 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00452192

    Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome

    Not yet reported University of Erlangen-Nürnberg Medical School 30 participants Est. completion 2009-12 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00470886

    Assessment of Compliance With Antihypertensive Telmisartan Therapy

    Bayer 3400 participants Est. completion 2010-01 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00471003

    The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

    Bayer 5448 participants Est. completion 2009-11 4 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00486187

    Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

    Not yet reported Dr. Milan Gupta 103 participants Est. completion 2009-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00490958

    Telmisartan in Haemodialysis Patients With Chronic Heart Failure

    Not yet reported University of Campania Luigi Vanvitelli 351 participants Est. completion 2005-06 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00509470

    Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine

    Not yet reported Tokyo University 75 participants Est. completion 2012-10 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00528385

    Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System

    Not yet reported Medical University of Gdansk
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00538486

    A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients

    Not yet reported Third Military Medical University 360 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT00539487

    Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives

    Boehringer Ingelheim 5827 participants 2389 sites
    Other conditions: Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT00550953

    Filtered Trial for Telmisartan 40mg Non-responder

    Not yet reported Boehringer Ingelheim 314 participants 5 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00553267

    Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension

    Not yet reported Boehringer Ingelheim 947 participants 97 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00558064

    Filtered Trial for Amlodipine Non-responder

    Not yet reported Boehringer Ingelheim 531 participants 41 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00558428

    Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension

    Not yet reported Boehringer Ingelheim 1098 participants 129 sites
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00559286

    Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels

    Not yet reported RWTH Aachen University 40 participants Est. completion 2009-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT00560430

    Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients

    Not yet reported Ludwig-Maximilians - University of Munich 56 participants Est. completion 2009-10 2 sites
    Metabolic syndrome Other conditions: Hypertension, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00562952

    Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients

    Not yet reported, Not yet reported Medical University of Vienna 300 participants Est. completion 2011-12 2 sites
    Heart failureCardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00599885

    Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes

    Not yet reported Korea University Anam Hospital 72 participants 1 site
    Cardiovascular disease Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Completed NCT NCT00613314

    Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen

    Boehringer Ingelheim 15268 participants 122 sites
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00614380

    Open Label Study Telmisartan and Amlodipine in Hypertension

    Not yet reported Boehringer Ingelheim 976 participants 122 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00615108

    Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters

    Boehringer Ingelheim 3148 participants 17 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00618774

    An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

    Not yet reported Boehringer Ingelheim 259 participants 7 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00624052

    26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension

    Not yet reported Boehringer Ingelheim 838 participants 92 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00638911

    Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

    Boehringer Ingelheim 33247 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00659581

    J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation

    Boehringer Ingelheim 21471 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00659607

    Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

    Boehringer Ingelheim 6901 participants 326 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00670787

    Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

    Not yet reported Kyushu University 207 participants Est. completion 2011-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00702936

    Telmisartan Versus Ramipril After Acute Coronary Syndrome

    Not yet reported Catholic University of the Sacred Heart 50 participants Est. completion 2008-11 1 site
    Cardiovascular disease Other conditions: Acute Coronary Syndrome, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00738660

    Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 30 participants Est. completion 2008-05 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00741585

    Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

    Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites
    Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00750113

    Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.

    Not yet reported Bayer 405 participants Est. completion 2009-08 43 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00847262

    Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes

    Not yet reported Third Military Medical University 120 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Hypertension, Obesity, Diabetes
    View official trial listing →
  • Completed NCT NCT00860262

    Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

    Not yet reported Boehringer Ingelheim 858 participants 137 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00863980

    Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

    Not yet reported Kyoto Prefectural University of Medicine 1500 participants Est. completion 2013-07 32 sites Stand-alone
    Cardiovascular disease Other conditions: Angina Pectoris, Myocardial Ischemia, Acute Coronary Syndrome, Hypertension
    View official trial listing →
  • Completed NCT NCT00865020

    Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal

    Not yet reported Novartis 822 participants Est. completion 2010-06 16 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00877929

    Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus

    Not yet reported Boehringer Ingelheim 706 participants 65 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00879411

    Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

    Boehringer Ingelheim 670 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00886288

    TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in Belgium

    Boehringer Ingelheim 2874 participants 936 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00890084

    Telmisartan Tab Hypertension

    Boehringer Ingelheim 2913 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00904215

    An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

    Boehringer Ingelheim 1095 participants 11 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00904371

    Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

    Boehringer Ingelheim 211 participants 36 sites
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00905528

    TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

    University of Erlangen-Nürnberg Medical School 69 participants Est. completion 2004-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00909038

    Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study

    Boehringer Ingelheim 2411 participants 915 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00926289

    Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

    Not yet reported Boehringer Ingelheim 894 participants 106 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00926341

    The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

    Not yet reported Aligarh Muslim University 110 participants Est. completion 2008-09 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00927537

    Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®

    Bayer 2052 participants Est. completion 2011-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00932867

    Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment

    Bayer 3114 participants Est. completion 2009-08 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00936208

    PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg

    Boehringer Ingelheim 3184 participants 120 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00939588

    Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

    Not yet reported Novartis Pharmaceuticals 88 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00946829

    Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

    Boehringer Ingelheim 18299 participants 12 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00981526

    Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia

    Not yet reported University of Massachusetts, Worcester 66 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00982735

    An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

    Boehringer Ingelheim 987 participants
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01011660

    Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 13542 participants Est. completion 2012-12 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01050062

    Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use

    Boehringer Ingelheim 1452 participants Est. completion 2011-12 314 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01071681

    Survey to Assess Why People Are Not Responding to Treatment in Hypertension

    Bayer 1589 participants Est. completion 2010-09 1 site
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01075698

    A Trial of Telmisartan Prevention of Cardiovascular Disease

    Not yet reported Kumamoto University 1228 participants Est. completion 2016-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01088295

    HIV and Fat Accumulation

    Not yet reported University of California, Los Angeles 35 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: HIV Infection
    View official trial listing →
  • Completed NCT NCT01103960

    An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy

    Not yet reported Boehringer Ingelheim 324 participants 16 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01108796

    Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan

    Boehringer Ingelheim 1856 participants Est. completion 2009-09 182 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01108809

    Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

    Boehringer Ingelheim 295 participants 49 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01128322

    CKD-828 Primary Hypertension Trial(Dose-selection)

    Not yet reported Chong Kun Dang Pharmaceutical 430 participants Est. completion 2011-03 26 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01134393

    TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

    Not yet reported Boehringer Ingelheim 502 participants 47 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01180205

    Telmisartan, Amlodipine and Flow Mediated Dilation

    Not yet reported Johannes Gutenberg University Mainz 576 participants Est. completion 2011-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01181011

    Telmisartan, Amlodipine and Combination in Healthy Subjects

    Not yet reported Boehringer Ingelheim 28 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01198496

    Recurrent Stroke Prevention Clinical Outcome Study

    Not yet reported Biomedis International Ltd. 5000 participants Est. completion 2019-12 1 site
    Cardiovascular disease Other conditions: Hypertension, Blood Pressure
    View official trial listing →
  • Terminated NCT NCT01202721

    Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)

    Not yet reported Hamilton Health Sciences Corporation 85 participants Est. completion 2016-11 13 sites Stand-alone
    Other conditions: Cardiac Disease
    View official trial listing →
  • Completed NCT NCT01204398

    Telmisartan+Amlodipine Fixed Dose Combination in Hypertension

    Not yet reported Boehringer Ingelheim 27 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01211171

    COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland

    Bayer 2498 participants Est. completion 2009-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01217879

    COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia

    Bayer 980 participants Est. completion 2010-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01222520

    Telmisartan 80mg Non-responder Trial

    Not yet reported Boehringer Ingelheim 174 participants 4 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01224860

    Telmisartan Versus Losartan in Kidney Transplantation

    Not yet reported Mario Negri Institute for Pharmacological Research 20 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01243268

    A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

    Boehringer Ingelheim 674 participants Est. completion 2016-08-18 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01246193

    CKD-828(80/2.5mg) Pharmacokinetic Study

    Not yet reported Chong Kun Dang Pharmaceutical 65 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01271478

    Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients

    Not yet reported Coordinación de Investigación en Salud, Mexico 60 participants Est. completion 2013-08-31 1 site Stand-alone
    Other conditions: Inflammation, End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01278797

    Telmisartan and Amlodipine Versus Monocomponent Tablets

    Not yet reported Boehringer Ingelheim 28 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01286558

    Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)

    Not yet reported Boehringer Ingelheim 225 participants 8 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01316419

    Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

    Boehringer Ingelheim 2089 participants Est. completion 2014-06 55 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01340131

    CKD-828 (40/5mg) Pharmacokinetic Study

    Not yet reported Chong Kun Dang Pharmaceutical 68 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01344629

    Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use

    Not yet reported Boehringer Ingelheim 64 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01352689

    CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

    Not yet reported Chong Kun Dang Pharmaceutical 67 participants Est. completion 2011-05 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01353274

    Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

    Boehringer Ingelheim 1157 participants Est. completion 2013-08 254 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01356017

    CKD-828 Drug Interaction Study (Telmisartan)

    Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Healthy Male Volunteers
    View official trial listing →
  • Completed NCT NCT01356043

    CKD-828 Drug Interaction Study (S-amlodipine)

    Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Healthy Male Volunteers
    View official trial listing →
  • Status unknown NCT NCT01377285

    Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

    Not yet reported National Taiwan University Hospital 350 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Completed NCT NCT01392534

    Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting

    Bayer 1586 participants Est. completion 2010-12 1 site
    Other conditions: Primary Hypertension
    View official trial listing →
  • Completed NCT NCT01426100

    CKD-828 Telmisartan Non-Responder Trial

    Not yet reported Chong Kun Dang Pharmaceutical 183 participants Est. completion 2012-08 18 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01435161

    Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF

    Not yet reported The Second Affiliated Hospital of Chongqing Medical University 160 participants Est. completion 2011-08 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01501253

    CKD-828 S-Amlodipine Non-Responder Trial

    Not yet reported Chong Kun Dang Pharmaceutical 187 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01541267

    The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria

    Not yet reported Medical University of Gdansk 20 participants Est. completion 2011-11
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT01578772

    A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

    Not yet reported University of California, Los Angeles 17 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT01634295

    Efficacy and Safety of CKD-828 to Stage 2 Hypertension

    Not yet reported Chong Kun Dang Pharmaceutical 103 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01683084

    Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms

    Not yet reported Palo Alto Veterans Institute for Research 22 participants Est. completion 2018-11-10 1 site
    Other conditions: Abdominal Aortic Aneurysm
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01748253

    ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)

    Not yet reported Acrobat Trial Group 80 participants 1 site
    Other conditions: Hypertension and Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01806363

    Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

    Not yet reported HanAll BioPharma Co., Ltd. 60 participants Est. completion 2013-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01819220

    Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

    Not yet reported Yonsei University 16 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01830530

    HIGH Altitude CArdiovascular REsearch in the ANDES

    Not yet reported Istituto Auxologico Italiano 100 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Hypertension, High Altitude
    View official trial listing →
  • Completed NCT NCT01842230

    Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

    Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Essential Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01842256

    Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

    Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Essential Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01885559

    HALT Progression of Polycystic Kidney Disease Study B

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 486 participants Est. completion 2014-06 7 sites
    Other conditions: Kidney, Polycystic
    View official trial listing →
  • Completed NCT NCT01911780

    Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine

    Not yet reported Boehringer Ingelheim 132 participants Est. completion 2015-01 17 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01914432

    Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

    Not yet reported Yuhan Corporation 210 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Hyperlipidemia, Hypertension
    View official trial listing →
  • Completed NCT NCT01928927

    Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 58 participants Est. completion 2016-03 12 sites Stand-alone
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT01975246

    Add-on to Micamlo BP Trial

    Not yet reported Boehringer Ingelheim 309 participants Est. completion 2014-07 30 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01975961

    PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin

    Not yet reported Yuhan Corporation 185 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Dyslipidemia & Hypertension
    View official trial listing →
  • Status unknown NCT NCT01983735

    Efficacy and Safety of TELMINUVO to Stage 2 Hypertension

    Not yet reported Chong Kun Dang Pharmaceutical 200 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01992601

    A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer

    Not yet reported Yuhan Corporation 48 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT01992796

    Angiotensin II Antagonist in Severe Sepsis

    Not yet reported University of Salerno 300 participants Est. completion 2017-01 1 site
    Other conditions: Severe Sepsis
    View official trial listing →
  • Completed NCT NCT01996085

    Non-invasive Haemodynamic Assessment in Hypertension

    Not yet reported Military Institute od Medicine National Research Institute 144 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT02047175

    CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

    Not yet reported Chong Kun Dang Pharmaceutical 64 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT02057328

    Comparative Study of the Effects of Telmisartan and Nebivolol

    Not yet reported Aristotle University Of Thessaloniki 80 participants Est. completion 2017-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02079805

    A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

    Not yet reported Takeda 33 participants Est. completion 2016-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT02085265

    Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

    Not yet reported Sunnybrook Health Sciences Centre 23 participants Est. completion 2025-02-28 10 sites Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Status unknown NCT NCT02087540

    Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

    Not yet reported IlDong Pharmaceutical Co Ltd 310 participants 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02121535

    Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use

    Not yet reported Boehringer Ingelheim 72 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02129192

    Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

    Not yet reported Boehringer Ingelheim 72 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02152969

    Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)

    Not yet reported Yuhan Corporation 66 participants Est. completion 2014-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02170246

    Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection

    Not yet reported Yale University 21 participants Est. completion 2018-06-13 2 sites Stand-alone
    Other conditions: Acute HIV Infection, HIV Infections
    View official trial listing →
  • Completed NCT NCT02172586

    Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients

    Not yet reported Boehringer Ingelheim 363 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02175355

    Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

    Not yet reported Boehringer Ingelheim 1039 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02176499

    Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension

    Not yet reported Boehringer Ingelheim 26 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02176512

    Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects

    Not yet reported Boehringer Ingelheim 20 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02176850

    Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

    Boehringer Ingelheim 19870 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177396

    MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring

    Not yet reported Boehringer Ingelheim 426 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177409

    Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension

    Not yet reported Boehringer Ingelheim 431 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177422

    Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

    Not yet reported Boehringer Ingelheim 489 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177435

    Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

    Not yet reported Boehringer Ingelheim 491 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177448

    BIBR 277 Capsule in Patients With Essential Hypertension

    Not yet reported Boehringer Ingelheim 225 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177461

    Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension

    Not yet reported Boehringer Ingelheim 374 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177487

    Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension

    Not yet reported Boehringer Ingelheim 100 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177500

    Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

    Not yet reported Boehringer Ingelheim 327 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02178306

    Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

    Not yet reported Boehringer Ingelheim 82 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02183675

    Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 36 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02183701

    Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

    Not yet reported Boehringer Ingelheim 715 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02187484

    BIBR 277 Capsules in Hypertensive Patients With Nephropathy

    Not yet reported Boehringer Ingelheim 23 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02187497

    Pharmacokinetics of BIBR 277 in Hypertensive Patients

    Not yet reported Boehringer Ingelheim 93 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02187523

    Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects

    Not yet reported Boehringer Ingelheim 32 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02187536

    Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy Subjects

    Not yet reported Boehringer Ingelheim 16 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02187705

    Micardis® in Patients With Essential Hypertension

    Boehringer Ingelheim 1688 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02193308

    Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 84 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02194309

    Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 24 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02200094

    Micardis®. Observational Study in Patients With Essential Hypertension

    Boehringer Ingelheim 4532 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02200575

    Pharmacovigilance and Patient Compliance in Hypertensive Patients

    Boehringer Ingelheim 10333 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02200640

    A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

    Not yet reported Boehringer Ingelheim 333 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02200653

    A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

    Not yet reported Boehringer Ingelheim 387 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02202525

    Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension

    Boehringer Ingelheim 2148 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02203500

    Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy Subjects

    Not yet reported Boehringer Ingelheim 26 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02206659

    Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension

    Not yet reported Boehringer Ingelheim 20 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02209649

    Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects

    Not yet reported Boehringer Ingelheim 12 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02213224

    Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

    Not yet reported Nanfang Hospital, Southern Medical University 180 participants Est. completion 2017-09 1 site Stand-alone
    MASLD
    View official trial listing →
  • Completed NCT NCT02214966

    Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 42 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02214979

    Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 84 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02214992

    Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 84 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02215005

    Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 42 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02215733

    The Use of Angiotensin Receptor Blockers and the Risk of Cancer

    Boehringer Ingelheim 1165781 participants
    Other conditions: Neoplasm
    View official trial listing →
  • Completed NCT NCT02218684

    Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects

    Not yet reported Boehringer Ingelheim 27 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02231788

    The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy

    Not yet reported Chong Kun Dang Pharmaceutical 217 participants Est. completion 2018-03 11 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02233218

    The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

    Not yet reported Yuhan Corporation 60 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Healthy Male Volunteer
    View official trial listing →
  • Completed NCT NCT02238262

    Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

    Boehringer Ingelheim 2318 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02238275

    Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

    Boehringer Ingelheim 8135 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242318

    Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

    Not yet reported Boehringer Ingelheim 440 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242331

    Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure

    Boehringer Ingelheim 19805 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242344

    Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

    Not yet reported Boehringer Ingelheim 77 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242357

    Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension

    Boehringer Ingelheim 14553 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242370

    Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension

    Not yet reported Boehringer Ingelheim 3045 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242383

    Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

    Boehringer Ingelheim 13248 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242396

    A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

    Boehringer Ingelheim 5248 participants
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT02242812

    Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension

    Not yet reported Boehringer Ingelheim 24 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242825

    Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus

    Boehringer Ingelheim 8148 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242838

    Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

    Boehringer Ingelheim 6336 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242851

    Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients

    Boehringer Ingelheim 5018 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242864

    Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure

    Boehringer Ingelheim 1527 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02242877

    TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older

    Boehringer Ingelheim 3320 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02243566

    Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

    Boehringer Ingelheim 2707 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02245464

    Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

    Boehringer Ingelheim 13066 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02248129

    Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

    Boehringer Ingelheim 4255 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02248896

    Antihypertensive Medications and the Risk of Sepsis

    Boehringer Ingelheim 1129062 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02250833

    CKD-828 (80/5mg) Pharmacokinetic Study

    Not yet reported Chong Kun Dang Pharmaceutical 69 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02255253

    Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population

    Not yet reported The George Institute for Global Health, China 1410 participants Est. completion 2015-03 14 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02259777

    Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 40 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02259790

    Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 30 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02259803

    Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 30 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02259816

    Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 38 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02259829

    Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 84 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02260089

    Telmisartan in Mild to Moderate Hypertensive Patients

    Not yet reported Boehringer Ingelheim 134 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02261064

    Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers

    Not yet reported Boehringer Ingelheim 32 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02261116

    Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 24 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02261129

    Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 64 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262559

    Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 30 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262572

    Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects

    Not yet reported Boehringer Ingelheim 24 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262585

    Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 30 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262598

    Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 30 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262611

    Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

    Boehringer Ingelheim 266 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02262624

    Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 36 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262637

    Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

    Boehringer Ingelheim 4814 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02262650

    Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects

    Not yet reported Boehringer Ingelheim 24 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262780

    Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 20 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262793

    Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects

    Not yet reported Boehringer Ingelheim 24 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262858

    Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II

    Not yet reported Boehringer Ingelheim 68 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02263989

    Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 30 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02264158

    Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 149 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02269176

    Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension

    Not yet reported Boehringer Ingelheim 330 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02276378

    Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 32 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02276391

    Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 64 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02338232

    Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported Hackensack Meridian Health 32 participants Est. completion 2023-01-05 1 site Stand-alone
    Other conditions: GVHD
    View official trial listing →
  • Completed NCT NCT02358824

    CKD-828 (80/5mg) Pharmacokinetic Study

    Not yet reported Chong Kun Dang Pharmaceutical 48 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02373163

    INTERVENCION Trial

    Not yet reported Prevencion 166 participants Est. completion 2016-06-01 1 site
    Other conditions: Blood Pressure, High
    View official trial listing →
  • Completed NCT NCT02387619

    The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

    Not yet reported Jeil Pharmaceutical Co., Ltd. 41 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02471833

    Health Evaluation in African Americans Using RAS Therapy

    Not yet reported, Not yet reported Emory University 61 participants Est. completion 2022-04-15 1 site Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02496910

    PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton

    Not yet reported Yuhan Corporation 180 participants Est. completion 2015-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02526875

    Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

    Not yet reported Chong Kun Dang Pharmaceutical 208 participants Est. completion 2017-11 10 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02579356

    To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers

    Not yet reported Samil Pharmaceutical Co., Ltd. 48 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Diseases of the Circulatory System, Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02593110

    Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease

    Not yet reported Northwestern University 114 participants Est. completion 2022-06-15 3 sites
    Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Terminated NCT NCT02608242

    PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

    Not yet reported Yuhan Corporation 123 participants Est. completion 2016-06 1 site
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02620163

    Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

    Not yet reported Yuhan Corporation 381 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02699645

    Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

    Not yet reported The George Institute 1671 participants Est. completion 2025-08-27 58 sites Stand-alone
    Other conditions: Intracerebral Haemorrhage (ICH), Hypertension
    View official trial listing →
  • Completed NCT NCT02734355

    Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation

    Not yet reported Research Institute for Complex Problems of Cardiovascular Diseases, Russia 64 participants Est. completion 2016-02
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02738632

    Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients

    Not yet reported IlDong Pharmaceutical Co Ltd 300 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02739672

    Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

    Not yet reported IlDong Pharmaceutical Co Ltd 40 participants Est. completion 2016-04-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02750059

    Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis

    Not yet reported SEARCH Research Foundation 21 participants Est. completion 2018-02 1 site Stand-alone
    Other conditions: Acute HIV Infection, HIV CNS Involvement
    View official trial listing →
  • Completed NCT NCT02768948

    Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?

    Not yet reported Centre Hospitalier Universitaire de Nice 20 participants Est. completion 2020-07-11 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02933658

    Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

    Not yet reported Daewon Pharmaceutical Co., Ltd. 71 participants Stand-alone
    Other conditions: Hypertension and Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02951962

    A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

    Not yet reported Yuhan Corporation 60 participants Est. completion 2016-09 1 site
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT02968160

    A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

    Not yet reported Yuhan Corporation 55 participants Est. completion 2018-02 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT03006341

    Validation of Predictors of OAC Initiation Using EMR Data

    Boehringer Ingelheim 140187 participants Est. completion 2017-05-09 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03021265

    To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

    Boehringer Ingelheim 676 participants Est. completion 2019-04-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03032315

    Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

    Not yet reported IlDong Pharmaceutical Co Ltd 44 participants Est. completion 2016-12-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03067688

    Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

    Not yet reported Yuhan Corporation 202 participants Est. completion 2018-03-27 1 site
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03088254

    Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

    Not yet reported Jeil Pharmaceutical Co., Ltd. 126 participants Est. completion 2017-12-04 12 sites Stand-alone
    Other conditions: Dyslipidemia With Hypertension
    View official trial listing →
  • Completed NCT NCT03116516

    Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin

    Not yet reported Yuhan Corporation 62 participants Est. completion 2017-05-26 1 site
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03143166

    Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan

    Not yet reported Boehringer Ingelheim 36 participants Est. completion 2017-08-02 1 site
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Withdrawn NCT NCT03205137

    Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

    Boehringer Ingelheim Est. completion 2022-07-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03210532

    Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

    Not yet reported Daewon Pharmaceutical Co., Ltd. 129 participants Est. completion 2017-09 1 site Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT03226340

    S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension

    Not yet reported Seoul National University Bundang Hospital 170 participants Est. completion 2018-03-31 10 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT03247140

    The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

    Not yet reported Jeil Pharmaceutical Co., Ltd. 40 participants Est. completion 2017-11-27 1 site Stand-alone
    Other conditions: Hypertension With Dyslipidemia
    View official trial listing →
  • Completed NCT NCT03267329

    Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

    Not yet reported Yuhan Corporation 80 participants Est. completion 2020-09-02 1 site Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Withdrawn NCT NCT03319823

    Treating Nocturnal Hypertension and Nocturia in African American Men

    Not yet reported Cedars-Sinai Medical Center Est. completion 2021-02-01 1 site Stand-alone
    Other conditions: High Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT03438955

    Phase I Drug-drug Interaction of Omega-3 and Atorvastatin

    Not yet reported DongKoo Bio & Pharma 48 participants Est. completion 2018-08-31 1 site
    Other conditions: Hyperlipidemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT03461081

    Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

    Not yet reported Jeil Pharmaceutical Co., Ltd. 32 participants Est. completion 2017-12-12 1 site Stand-alone
    Other conditions: Hypertension With Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03474562

    High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

    Not yet reported Yuhan Corporation 100 participants Est. completion 2019-06-07 4 sites Stand-alone
    Cardiovascular diseasePrediabetes Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT03504566

    Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)

    Not yet reported Steno Diabetes Center Copenhagen Est. completion 2019-06-01 1 site
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT03550859

    HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria

    Not yet reported Yuhan Corporation 374 participants Est. completion 2021-12 16 sites Stand-alone
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT03566316

    Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

    Not yet reported IlDong Pharmaceutical Co Ltd 134 participants Est. completion 2017-06-16 1 site Stand-alone
    Other conditions: Hypertension With Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03662620

    Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

    Not yet reported Yuhan Corporation 67 participants Est. completion 2018-12-22 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03705533

    Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State

    Not yet reported Pharmtechnology LLC 26 participants Est. completion 2018-12-19 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT03707899

    The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

    Not yet reported Jeil Pharmaceutical Co., Ltd. 49 participants Est. completion 2019-05-22 1 site Stand-alone
    Other conditions: Hypertension With Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT03742544

    Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy

    IlDong Pharmaceutical Co Ltd 600 participants Est. completion 2020-10-30
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Terminated NCT NCT03783754

    Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study

    Not yet reported The George Institute 4 participants Est. completion 2021-03-21 3 sites Stand-alone
    Cardiovascular disease Other conditions: Cerebral Small Vessel Diseases, Intracerebral Hemorrhage, Vascular Dementia, Hypertension
    View official trial listing →
  • Terminated NCT NCT03785067

    Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study

    Not yet reported The George Institute 1 participants Est. completion 2021-02-03 4 sites Stand-alone
    Cardiovascular disease Other conditions: Cognitive Decline, Intracerebral Hemorrhage, Dementia, Vascular, Cerebral Small Vessel Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT03860220

    The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

    Not yet reported Hyo-Soo Kim 252 participants Est. completion 2023-09-07 9 sites
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Terminated NCT NCT03868839

    Telmisartan Pilot Study on Treatment Resistant Schizophrenia

    Not yet reported Xiaoduo Fan 6 participants Est. completion 2020-10-07 1 site Stand-alone
    Other conditions: Schizophrenia, Schizo Affective Disorder, Treatment-resistant Schizophrenia
    View official trial listing →
  • Completed NCT NCT03872232

    Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan

    Not yet reported Addpharma Inc. 180 participants Est. completion 2020-08-12 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Hypertension
    View official trial listing →
  • Completed NCT NCT03889145

    A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

    Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2014-02-19 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03956823

    Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2021-12-01 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT04021550

    Improving 24-hour Blood Pressure in Obstructive Sleep Apnea

    Not yet reported University of British Columbia Est. completion 2026-12 Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT04061824

    Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

    Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04158076

    Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

    Not yet reported Addpharma Inc. 131 participants Est. completion 2021-01-14 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Hypertension
    View official trial listing →
  • Completed NCT NCT04218552

    Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension

    Not yet reported Addpharma Inc. 176 participants Est. completion 2021-02-25 1 site
    Other conditions: Hypertension,Essential
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04354350

    Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data

    Brigham and Women's Hospital 63744 participants Est. completion 2021-02-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04354376

    Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data

    Brigham and Women's Hospital 40048 participants Est. completion 2021-02-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04355936

    Telmisartan for Treatment of COVID-19 Patients

    Not yet reported Laboratorio Elea Phoenix S.A. 400 participants Est. completion 2020-11-30 2 sites Stand-alone
    Other conditions: COVID-19 Drug Treatment
    View official trial listing →
  • Completed NCT NCT04356495

    Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation

    Not yet reported, Not yet reported University Hospital, Bordeaux 412 participants Est. completion 2021-10-22 7 sites Stand-alone
    Other conditions: Corona Virus Infection, Sars-CoV2
    View official trial listing →
  • Terminated NCT NCT04359953

    Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19

    Not yet reported University Hospital, Strasbourg, France 16 participants Est. completion 2022-06-01 1 site Stand-alone
    Other conditions: COVID-19 Infection
    View official trial listing →
  • Terminated NCT NCT04360551

    Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients

    Not yet reported University of Hawaii 24 participants Est. completion 2022-04-26 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04394117

    Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

    Not yet reported The George Institute 787 participants Est. completion 2022-01-17 22 sites
    Other conditions: Coronavirus Disease 2019, COVID-19
    View official trial listing →
  • Completed NCT NCT04436419

    Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study

    Not yet reported Fauqué 40 participants Est. completion 2020-03-16 1 site
    Other conditions: Obesity, Obesity, Abdominal, Obesity, Visceral, Female
    View official trial listing →
  • Completed NCT NCT04466241

    Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

    Not yet reported, Not yet reported ANRS, Emerging Infectious Diseases 294 participants Est. completion 2021-11-01 2 sites Stand-alone
    Other conditions: COVID-19, COVID-19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Completed NCT NCT04510662

    Telmisartan in Respiratory Failure Due to COVID-19

    Not yet reported Abraham Edgar Gracia-Ramos 66 participants Est. completion 2021-05-25 1 site Stand-alone
    Other conditions: COVID-19, Respiratory Insufficiency, Telmisartan, Respiratory Distress Syndrome, Adult
    View official trial listing →
  • Completed NCT NCT04518293

    Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

    Not yet reported George Medicines PTY Limited 1385 participants Est. completion 2023-09-01 89 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04518306

    Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension

    Not yet reported George Medicines PTY Limited 755 participants Est. completion 2023-10-18 47 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT04606563

    Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

    Not yet reported University of British Columbia 341 participants Est. completion 2022-04-22 13 sites Stand-alone
    Other conditions: Covid19, SARS-CoV Infection
    View official trial listing →
  • Status unknown NCT NCT04659070

    To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia

    Not yet reported Hanlim Pharm. Co., Ltd. 156 participants Est. completion 2022-05-19 1 site Stand-alone
    Other conditions: Primary Hypercholesterolemia, Hypertension
    View official trial listing →
  • Completed NCT NCT04667624

    Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

    Not yet reported Hanlim Pharm. Co., Ltd. 32 participants Est. completion 2020-05-18 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT04715763

    INvestigating TELmisartin Study

    Not yet reported University of Hawaii 24 participants Est. completion 2022-04-26 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04736329

    Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions

    Not yet reported Cairo University 107 participants Est. completion 2022-10-31 1 site
    Heart failure Other conditions: Renal Insufficiency
    View official trial listing →
  • Status unknown NCT NCT04743063

    Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

    Brigham and Women's Hospital 40000 participants Est. completion 2022-12-31 1 site
    Heart failure Other conditions: Frailty
    View official trial listing →
  • Status unknown NCT NCT04920838

    Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection

    Not yet reported, Not yet reported ANRS, Emerging Infectious Diseases 600 participants Est. completion 2023-08 2 sites Stand-alone
    Other conditions: Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Infection
    View official trial listing →
  • Withdrawn NCT NCT04970108

    Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension

    Not yet reported EMS Est. completion 2025-05 Stand-alone
    Other conditions: Hypertension Associated, Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT05040880

    A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers

    Not yet reported HK inno.N Corporation 46 participants Est. completion 2021-10-31 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT05144360

    Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension

    Not yet reported EMS Est. completion 2024-11 Stand-alone
    Other conditions: Hypertension Associated, Type II Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT05155436

    Occurrence of Dyskalemia With Treatment for Hypertension

    Not yet reported National Heart Foundation of Bangladesh 1090 participants Est. completion 2023-03-31 1 site Stand-alone
    Other conditions: Hypertension, Potassium Imbalance
    View official trial listing →
  • Status unknown NCT NCT05223101

    A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

    Not yet reported HK inno.N Corporation 46 participants Est. completion 2022-07 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05322889

    Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)

    Not yet reported Dr. Frank Behrens 35 participants Est. completion 2023-06-30 1 site Stand-alone
    Other conditions: Neuropathic Pain, Chemotherapy Effect
    View official trial listing →
  • Status unknown NCT NCT05328310

    Effect of Different Antihypertensive Drugs on Central Blood Pressure

    Not yet reported Korea University Anam Hospital 110 participants Est. completion 2026-03 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05843162

    A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome

    Not yet reported Chong Kun Dang Pharmaceutical 116 participants Est. completion 2023-12-31 Stand-alone
    Metabolic syndrome Other conditions: Essential Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT06041529

    Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

    Not yet reported Yuhan Corporation 198 participants Est. completion 2026-02-28 15 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT06063109

    A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.

    Not yet reported THPharm Corp. 51 participants Est. completion 2023-11-09 1 site Stand-alone
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT06214832

    An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)

    Hanlim Pharm. Co., Ltd. 4000 participants Est. completion 2025-08-30 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT06282549

    Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

    Yuhan Corporation 1219 participants Est. completion 2027-03-31 5 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT06431477

    Efficacy and Safety of Telmisartan Compared With Losartan

    Not yet reported Chong Kun Dang Pharmaceutical 98 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Diabetic Nephropathies, Hypertension
    View official trial listing →
  • Terminated NCT NCT06483789

    Efficacy and Safety of HB-1 for Panic Disorder

    Not yet reported HB BioTech, LLC 170 participants Est. completion 2026-09-09 19 sites Stand-alone
    Other conditions: Panic Disorder, Mental Illness
    View official trial listing →
  • Status unknown NCT NCT06515652

    To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome

    Not yet reported Hamdard University 200 participants Est. completion 2024-08-30 1 site
    Metabolic syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07030101

    A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

    Not yet reported EMS 400 participants Est. completion 2029-11
    Other conditions: Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07370506

    Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

    Not yet reported, Not yet reported Tanta University 36 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Breast Cancer, Doxorubicin Induced Cardiomyopathy
    View official trial listing →
  • Enrolling by invitation NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Enrolling by invitation NCT NCT07568574

    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

    Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-alone
    Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
    View official trial listing →
  • Completed NCT NCT07652567

    Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive Population

    Not yet reported Qilu Hospital of Shandong University 690 participants Est. completion 2026-04-30 1 site Stand-alone
    Other conditions: High-normal Blood Pressure
    View official trial listing →
  • Not yet recruiting NCT NCT07784608

    A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult Volunteers

    Not yet reported Huons Co., Ltd. 28 participants Est. completion 2027-11 1 site Stand-alone
    Other conditions: Drug-drug Interactions
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Telmisartan, Micardis HCT, Micardis

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.